Belgian Real Estate Stock News

Why Sipef’s latest half year earnings matter for shareholders Sipef (ENXTBR:SIP) shares moved after the company released half year results on 12 August 2026. Sales reached US$308.04 million and net income was US$60.15 million, compared with the prior year period. See our latest analysis for Sipef. The earnings release on 12 August appears to have shifted sentiment around Sipef, with a 7 day share price return of 12.75% and a year to date share price return of 24.51% alongside a 5 year total...

Sipef heads into this earnings season with the stock at €102.60 after a solid run over the past month. Yet the real story sits in the profit line. The latest half year shows revenue of US$308.0m and basic earnings per share of US$5.75, which keeps the trailing twelve month P/E at 9.7. That is well below the wider European food sector. The market is wrestling with this valuation gap against a net margin of 20.4% and strong trailing earnings growth, while analyst forecasts still flag pressure...

Sipef NV recently reported past half-year results for the period ended June 30, 2026, with sales rising to US$308.04 million from US$250.43 million and net income increasing to US$60.15 million from US$57.72 million a year earlier. The company also delivered higher basic earnings per share from continuing operations, up to US$5.75 compared with US$5.54 in the prior-year period, pointing to improved profitability per share. With this earnings report showing growth in both revenue and...

Recent commentary points to rising analyst optimism around Anheuser-Busch InBev (ENXTBR:ABI), driven by upward revisions to earnings estimates and expectations for above average EPS growth. This has brought fresh attention to the stock. See our latest analysis for Anheuser-Busch InBev. The latest analyst optimism comes against a backdrop where Anheuser-Busch InBev’s share price has risen strongly year to date, with a 28.01% year-to-date share price return and a 35.27% total shareholder return...

Nextensa stock closed at €45.6 on Thursday, only slightly ahead over the past week and weaker over one and three months, even as the latest half year release sharpened the focus on valuation strain. The company now sits on trailing earnings per share of €2.99 and a P/E of 15.2x, above Belgian peers at 9x and the wider European real estate investment trust sector at 14.3x. Set that against a discounted cash flow estimate of €21.72 per share and it highlights the valuation questions investors...

Shurgard Self Storage stock closed at €24.65 today, with the recent 7 day slide and 30 day decline suggesting investors are reacting nervously to the latest earnings. The headline is not revenue, which sits at €115.054m for the quarter. The real story is pressure on profitability as adjusted earnings and net operating income growth trail the expansion of the store pipeline and rentable space. In the very near term that squeeze is what the market is trading. Over a multi year horizon the...

Cenergy Holdings (ENXTBR:CENER) has drawn attention after strong half year 2026 earnings, a higher full year guidance range for adjusted EBITDA, and a record order backlog supported by a large Greek grid frame agreement. See our latest analysis for Cenergy Holdings. Cenergy Holdings’ share price has moved to €22.32, with a 42.17% year to date share price return and a 1 year total shareholder return of 97.87%, while the 3 month share price return has declined 15.45%. This suggests strong...

KBC Group (ENXTBR:KBC) has given investors fresh information to assess after raising its 2026 earnings guidance, reporting higher net income for the second quarter and first half, and affirming a €1 interim dividend for November 2026. See our latest analysis for KBC Group. At a share price of €129.65, KBC Group has posted a 7.55% 1 month share price return and a 14.23% year to date share price return, alongside a 30.51% 1 year total shareholder return. This points to momentum building as...

Shareholders of Lotus Bakeries NV ( EBR:LOTB ) will be pleased this week, given that the stock price is up 11% to...

Q2 2026 results and fresh outlook put Melexis in focus Melexis (ENXTBR:MELE) drew fresh attention after reporting Q2 2026 results that showed higher sales but lower net income compared with a year earlier, alongside new guidance for Q3 and the second half of 2026. The company also affirmed an interim dividend of €1.30 per share, with shares due to trade ex coupon on 13 October 2026 and the record date set for 14 October 2026. Investors now have updated figures for both earnings and...

Syensqo (ENXTBR:SYENS) is back in focus after reporting second quarter and first half 2026 results, with quarterly sales at €1,611 million and quarterly net income at €24 million. See our latest analysis for Syensqo. Since the earnings release on 30 July 2026, Syensqo’s share price has pushed higher, with a 30 day share price return of 23.79% and a 90 day share price return of 36.05%, suggesting momentum has been building. The 1 year total shareholder return of 10.35% points to more modest...

Why the latest FINTEPLA data and earnings matter for UCB stock UCB (ENXTBR:UCB) has drawn fresh attention after new EpilepsiaOpen data on FINTEPLA in Lennox Gastaut syndrome, alongside a half year 2026 earnings update showing higher sales, revenue and net income versus a year earlier. See our latest analysis for UCB. Recent FINTEPLA data and the strong half year 2026 results have arrived while UCB’s 1 year total shareholder return of 21.46% contrasts with a year to date share price return...

The EU’s new anti dumping tariffs on terephthalic acid have suddenly shifted the ground under Europe’s chemicals and specialty materials stocks. Supply routes into a €1.4b market are being rewired, which can change pricing power and margins for certain producers. This article looks at three European stocks directly exposed to this news and explains how each could be affected, so you can decide whether they deserve a closer look now. The stocks covered below are just a starting sample, and the...

Why the latest Umicore earnings matter for investors Umicore (ENXTBR:UMI) drew fresh attention after reporting half year 2026 results, with sales of €13,920.2 million, revenue of €14,020.9 million and net income of €239.8 million, alongside higher earnings per share. See our latest analysis for Umicore. Umicore’s latest half year earnings update has come alongside a sharp shift in sentiment, with the share price up 11.10% over the past week and a 1 year total shareholder return of 74.83%...

What Azelis Group’s latest earnings tell you Azelis Group (ENXTBR:AZE) has just reported half year 2026 results, giving investors fresh numbers to assess the stock. Sales and revenue were slightly above the prior year, with net income and earnings per share also higher. See our latest analysis for Azelis Group. The latest half year earnings have arrived alongside a sharp pick up in momentum for Azelis Group, with a 1 month share price return of 16.21% and a year to date share price return of...

KBC Group NV ( EBR:KBC ) just released its quarterly report and things are looking bullish. The company beat...

Bpost/SA went into this earnings release with the stock already under pressure, down around 19% over the past three months and closing at €1.36 on 7 August. The headline is simple: the earnings report sharpened the focus on a profit squeeze that investors were already worrying about. Management cut full year adjusted earnings before interest and tax guidance to about €140m after a costly April strike and a slower revenue ramp at Paxon. Quarterly revenue of €1,046.4m and another small net loss...

argenx (ENXTBR:ARGX) has launched a tender offer to acquire Forte Biosciences in a deal backed by Forte's Board of Directors. The offer gives Forte shareholders the option to sell their shares directly into argenx's bid under agreed terms. The Forte Board's recommendation signals alignment on the transaction and may help smooth the path to completion. Moves like argenx's push into additional clinical assets are part of a broader search for under-covered growth stories in healthcare, and you...

Lotus Bakeries stock went into this earnings print priced for perfection, trading on a trailing P/E of 56.9x against far lower food sector averages. The market had already rewarded the story, with double digit revenue and earnings growth over the past year, so any hint of strain was always going to hit sentiment hard. The real hinge of this release is valuation pressure. The shares sit well above a discounted cash flow estimate of €8,005.35, which puts every line of the H1 2026 report under a...

Investors in Nyxoah SA ( EBR:NYXH ) had a good week, as its shares rose 3.9% to close at €1.27 following the release of...

Earnings setback puts Proximus stock in focus Proximus (ENXTBR:PROX) is back on investors' radar after first half 2026 results showed lower sales, revenue, and net income compared with a year earlier, sharpening attention on the company's earnings power. See our latest analysis for Proximus. Since the July earnings announcement, Proximus has seen its share price slip 1.3% on the day and 2.3% over the past week. However, the 30 day share price return is up 6.9% while the 1 year total...

Jensen-Group’s stock has slipped over the past week and month, even as the latest earnings landed with a very different message. The market is trading the recent softness, yet the fresh report shows a laundry equipment specialist that is still producing solid profit and cash generation. The tension comes from one place: margins are thinner than a year ago, with net profit margin over the last twelve months sitting below the prior period. That squeeze is colliding with a P/E of 12.3x that...

Anheuser-Busch InBev SA/NV's ( EBR:ABI ) robust earnings report didn't manage to move the market for its stock. Our...

Why NV Bekaert’s latest earnings matter for shareholders NV Bekaert (ENXTBR:BEKB) has just reported half year 2026 results that show lower sales but higher net income and earnings per share compared with the same period last year. That mix deserves closer attention. For the half year to 30 June 2026, the company reported sales of €1,863.27m compared with €1,953.08m a year earlier. Over the same period, net income was €94.31m compared with €81.72m. Basic earnings per share from continuing...